Cargando…

Next RNA Therapeutics: The Mine of Non-Coding

The growing knowledge on several classes of non-coding RNAs (ncRNAs) and their different functional roles has aroused great interest in the scientific community. Beyond the Central Dogma of Biology, it is clearly known that not all RNAs code for protein products, and they exert a broader repertoire...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbo, Sabrina, Maione, Rossella, Tripodi, Marco, Battistelli, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267739/
https://www.ncbi.nlm.nih.gov/pubmed/35806476
http://dx.doi.org/10.3390/ijms23137471
_version_ 1784743806805999616
author Garbo, Sabrina
Maione, Rossella
Tripodi, Marco
Battistelli, Cecilia
author_facet Garbo, Sabrina
Maione, Rossella
Tripodi, Marco
Battistelli, Cecilia
author_sort Garbo, Sabrina
collection PubMed
description The growing knowledge on several classes of non-coding RNAs (ncRNAs) and their different functional roles has aroused great interest in the scientific community. Beyond the Central Dogma of Biology, it is clearly known that not all RNAs code for protein products, and they exert a broader repertoire of biological functions. As described in this review, ncRNAs participate in gene expression regulation both at transcriptional and post-transcriptional levels and represent critical elements driving and controlling pathophysiological processes in multicellular organisms. For this reason, in recent years, a great boost was given to ncRNA-based strategies with potential therapeutic abilities, and nowadays, the use of RNA molecules is experimentally validated and actually exploited in clinics to counteract several diseases. In this review, we summarize the principal classes of therapeutic ncRNA molecules that are potentially implied in disease onset and progression, which are already used in clinics or under clinical trials, highlighting the advantages and the need for a targeted therapeutic strategy design. Furthermore, we discuss the benefits and the limits of RNA therapeutics and the ongoing development of delivery strategies to limit the off-target effects and to increase the translational application.
format Online
Article
Text
id pubmed-9267739
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92677392022-07-09 Next RNA Therapeutics: The Mine of Non-Coding Garbo, Sabrina Maione, Rossella Tripodi, Marco Battistelli, Cecilia Int J Mol Sci Review The growing knowledge on several classes of non-coding RNAs (ncRNAs) and their different functional roles has aroused great interest in the scientific community. Beyond the Central Dogma of Biology, it is clearly known that not all RNAs code for protein products, and they exert a broader repertoire of biological functions. As described in this review, ncRNAs participate in gene expression regulation both at transcriptional and post-transcriptional levels and represent critical elements driving and controlling pathophysiological processes in multicellular organisms. For this reason, in recent years, a great boost was given to ncRNA-based strategies with potential therapeutic abilities, and nowadays, the use of RNA molecules is experimentally validated and actually exploited in clinics to counteract several diseases. In this review, we summarize the principal classes of therapeutic ncRNA molecules that are potentially implied in disease onset and progression, which are already used in clinics or under clinical trials, highlighting the advantages and the need for a targeted therapeutic strategy design. Furthermore, we discuss the benefits and the limits of RNA therapeutics and the ongoing development of delivery strategies to limit the off-target effects and to increase the translational application. MDPI 2022-07-05 /pmc/articles/PMC9267739/ /pubmed/35806476 http://dx.doi.org/10.3390/ijms23137471 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Garbo, Sabrina
Maione, Rossella
Tripodi, Marco
Battistelli, Cecilia
Next RNA Therapeutics: The Mine of Non-Coding
title Next RNA Therapeutics: The Mine of Non-Coding
title_full Next RNA Therapeutics: The Mine of Non-Coding
title_fullStr Next RNA Therapeutics: The Mine of Non-Coding
title_full_unstemmed Next RNA Therapeutics: The Mine of Non-Coding
title_short Next RNA Therapeutics: The Mine of Non-Coding
title_sort next rna therapeutics: the mine of non-coding
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267739/
https://www.ncbi.nlm.nih.gov/pubmed/35806476
http://dx.doi.org/10.3390/ijms23137471
work_keys_str_mv AT garbosabrina nextrnatherapeuticsthemineofnoncoding
AT maionerossella nextrnatherapeuticsthemineofnoncoding
AT tripodimarco nextrnatherapeuticsthemineofnoncoding
AT battistellicecilia nextrnatherapeuticsthemineofnoncoding